Effect of ranibizumab combined with vitrectomy on the serum VEGF-A and SDF-1 expression in patients with proliferative diabetic retinopathy
AIM:To discuss the effect of ranibizumab combined with vitrectomy(VT)on the serum vascular endothelial growth factor A(VEGF-A)and human stromal cell derived factor 1(SDF-1)expression in patients with PDR.<p>METHODS: Totally 120 patients with PDR were selected from January 2017 to January 2018...
Main Authors: | Wen Luo, Mei Ming |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2019-03-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://ies.ijo.cn/cn_publish/2019/3/201903021.pdf |
Similar Items
-
Clinical observation of minimally invasive vitrectomy assisted by Ranibizumab on severe proliferative diabetic retinopathy
by: Ling Huang, et al.
Published: (2018-08-01) -
Curative effect of 23G micro-invasive vitrectomy combined with intravitreal injection of Ranibizumab in the treatment of proliferative diabetic retinopathy
by: Wei Han, et al.
Published: (2021-03-01) -
Effect of ranibizumab on the efficacy of vitrectomy in patients with PDR
by: Xiao Dong
Published: (2019-05-01) -
Efficacy comparison of Conbercept and Ranibizumab as pre-treatment for pars plana vitrectomy in proliferative diabetic retinopathy
by: Ni Yin, et al.
Published: (2017-07-01) -
Curative effect of intravitreal injection of ranibizumab combined with vitrectomy for PDR
by: Li-Xiao Shang, et al.
Published: (2019-05-01)